A Study to Investigate Zanubrutinib in Chinese Participants With B-cell Lymphoma
Clinical trial NCT03189524 · COMPLETED
Trial details
- NCT number
- NCT03189524
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-05
- Primary completion
- 2020-08-26
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.